Addex Therapeutics (ADXN) Current Leases (2022 - 2025)
Historic Current Leases for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to $9481.8.
- Addex Therapeutics' Current Leases rose 1386.0% to $9481.8 in Q3 2025 from the same period last year, while for Sep 2025 it was $9481.8, marking a year-over-year increase of 1386.0%. This contributed to the annual value of $8304.7 for FY2024, which is 9727.74% down from last year.
- According to the latest figures from Q3 2025, Addex Therapeutics' Current Leases is $9481.8, which was up 1386.0% from $9048.3 recorded in Q2 2025.
- In the past 5 years, Addex Therapeutics' Current Leases ranged from a high of $316291.6 in Q1 2022 and a low of $8228.4 during Q1 2025
- Moreover, its 4-year median value for Current Leases was $222306.1 (2023), whereas its average is $149218.6.
- As far as peak fluctuations go, Addex Therapeutics' Current Leases crashed by 9729.96% in 2024, and later soared by 1386.0% in 2025.
- Addex Therapeutics' Current Leases (Quarter) stood at $296985.3 in 2022, then rose by 3.99% to $308845.5 in 2023, then tumbled by 97.3% to $8340.0 in 2024, then rose by 13.69% to $9481.8 in 2025.
- Its Current Leases stands at $9481.8 for Q3 2025, versus $9048.3 for Q2 2025 and $8228.4 for Q1 2025.